Evidence map›Paper›PMID 39887052›Full record

ArticleBiometrics2025

A regularized Bayesian Dirichlet-multinomial regression model for integrating single-cell-level omics and patient-level clinical study data.

Yanghong Guo, Lei Yu, Lei Guo, Lin Xu, Qiwei Li

Abstract read
In one paragraph

Article in Biometrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Yanghong GuoDepartment of Mathematical Sciences, The University of Texas at Dallas, Richardson, TX 75080, United States.
Lei YuQuantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
Lei GuoQuantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
Lin XuQuantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.ORCID 0000-0001-5815-4457
Qiwei LiDepartment of Mathematical Sciences, The University of Texas at Dallas, Richardson, TX 75080, United States.ORCID 0000-0002-1020-3050

Funding

Multiscale functional characterization of genomic variation in human developmental disordersUM1HG011996 · NHGRI · UT SOUTHWESTERN MEDICAL CENTER · PI Gary Chung Hon, WILLIAM Lee KRAUS · 2021 to 2026
$10.5M
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.R01DK127037 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI NOAH Freeman SHROYER, Ergun Sahin · 2022 to 2026
$3.3M
Unraveling ApoE4 Promotion of Cardiometabolic DiseaseR01HL144969 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAUL, PHILIP W · 2020 to 2023
$2.6M
Reprogramming myeloid cells to inhibit cancer developmentR01CA263079 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHENGCHENG ZHANG · 2022 to 2026
$1.9M
Developing novel algorithms for spatial molecular profiling technologiesR01GM141519 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2021 to 2024
$1.4M
Identifying neuroblastoma drivers and bringing them to the clinicR21CA259771 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SKAPEK, STEPHEN X, XU, LIN · 2021 to 2021
$437k
National Science Foundation 2210912NCI NIH HHS R01 CA263079NCI NIH HHS R21 CA259771NHGRI NIH HHS UM1 HG011996NHLBI NIH HHS R01 HL144969NIDDK NIH HHS R01 DK127037NIGMS NIH HHS R01 GM141519NIH HHS 1R01GM141519
6 · The paper itself

Abstract

The abundance of various cell types can vary significantly among patients with varying phenotypes and even those with the same phenotype. Recent scientific advancements provide mounting evidence that other clinical variables, such as age, gender, and lifestyle habits, can also influence the abundance of certain cell types. However, current methods for integrating single-cell-level omics data with clinical variables are inadequate. In this study, we propose a regularized Bayesian Dirichlet-multinomial regression framework to investigate the relationship between single-cell RNA sequencing data and patient-level clinical data. Additionally, the model employs a novel hierarchical tree structure to identify such relationships at different cell-type levels. Our model successfully uncovers significant associations between specific cell types and clinical variables across three distinct diseases: pulmonary fibrosis, COVID-19, and non-small cell lung cancer. This integrative analysis provides biological insights and could potentially inform clinical interventions for various diseases.

Indexed as

Single-Cell AnalysisBayes TheoremCarcinoma, Non-Small-Cell LungCOVID-19HumansLung NeoplasmsModels, StatisticalPulmonary FibrosisRegression AnalysisSARS-CoV-2Sequence Analysis, RNADirichlet-multinomial regression modelshierarchical treeintegrative analysissingle-cell RNA sequencingspike-and-slap priors

Identifiers

PMID39887052
PMCPMC11783250

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.